NKGN logo

NKGen Biotech (NKGN)

Profile

Full Name

NKGen Biotech, Inc.

Ticker Symbol

NKGN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 2, 2023

Indexes

Not included

Website

http://nkgenbiotech.com

Employees

63

Key Details

Price

$0.12(+4.35%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$5.38(-555.62% YoY)

PE ratio

-

Next earnings date

May 20, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$0.12
NKGN price is $0.12

30-Day Relative Volume

0.91
NKGN 30-day relative volume is 0.91

Price Performance

Price Today change

+4.35%
NKGN price is up +4.35% today

Price YTD change

-81.68%
NKGN price is down -81.68% since January 1st

Price 1-year change

-90%
NKGN price is down -90% year-on-year

Price 3-year change

-
NKGN price 3-year change is unknown

Price Range

Price All-time high

$6.70
NKGN price is currently -98.21% below its historical high of $6.70

Price 3-year low

$0.10
NKGN price is currently +22.45% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$5.43M
NKGN market capitalization is $5.43 million

Market cap 3-year change

-
NKGN market capitalization 3-year change is unknown

Market cap All-time high

$124.99M
NKGN market capitalization is currently -95.65% below its historical high of $124.99 million

Market cap sector rank

14.22%
NKGN market capitalization is higher than 14.22% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+102.25%
NKGN shares outstanding is up +102.25% year-on-year

Shares Outstanding 3-Year Change

-
NKGN shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.83
NKGN beta is 0.83

200-day SMA

$0.56
NKGN price is currently -78.70% below its 200-day simple moving average

50-day SMA

$0.32
NKGN price is currently -62.43% below its 50-day simple moving average

RSI

36.55
NKGN 14-day relative strength index is 36.55

Volume

0.91
NKGN 30-day relative volume is 0.91

ATR

$0.05
NKGN average true range is $0.05

10-day Historical Volatility

252.97%
NKGN 10-day historical volatility is 252.97%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
NKGN annual revenue value is unknown

Revenue Analysts estimate

-
NKGN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
NKGN annual revenue 1-year change is unknown

Revenue Sector rank

-
NKGN annual revenue is unknown

EPS

EPS

-$5.38
NKGN annual earnings per share is -$5.38

EPS Analysts estimate

-
NKGN annual earnings per share consensus analysts' forecast is unknown

EPS 1-year change

-555.62%
NKGN annual earnings per share is down -555.62% year-on-year

EPS Sector rank

18.08%
NKGN annual earnings per share is higher than 18.08% of companies in Healthcare sector

Profit

Gross profit

$0.00
NKGN annual gross profit is $0.00

Gross margin

-
NKGN annual gross profit margin value is unknown

Operating profit

-$29.75M
NKGN annual operating income is -$29.75 million

Operating margin

-
NKGN annual operating profit margin value is unknown

Net income

-$82.95M
NKGN annual net profit is -$82.95 million

Net margin

-
NKGN annual net profit margin value is unknown

Expenses

Total expenses

$29.75M
NKGN annual total expenses is $29.75 million

Operating expenses

$29.75M
NKGN annual total operating expenses is $29.75 million

Cost of goods sold

-
NKGN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$14.08M
NKGN annual SGA is $14.08 million

Depreciation and amortization

$1.20M
NKGN annual depreciation & amortization is $1.20 million

Interest expense

$745.00K
NKGN annual interest expense is $745.00 thousand

Income tax

$7000.00
NKGN annual income tax is $7000.00

EBIT & EBITDA

EBIT

-$82.20M
NKGN annual earnings before interest & taxes is -$82.20 million

EBITDA

-$81.00M
NKGN annual EBITDA is -$81.00 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$16.48M
NKGN annual total assets is $16.48 million

Non current assets

$14.55M
NKGN annual long term assets is $14.55 million

Current assets

$1.93M
NKGN annual total current assets is $1.93 million

Cash and cash equivalents

$26.00K
NKGN annual cash & cash equivalents is $26.00 thousand

Accounts receivable

$0.00
NKGN annual accounts receivable is $0.00

Inventory

-
NKGN annual inventory value is unknown

Liabilities

Total liabilities

$75.17M
NKGN annual total liabilities is $75.17 million

Long term liabilities

$35.72M
NKGN annual total long term liabilities is $35.72 million

Current liabilities

$39.45M
NKGN annual total current liabilities is $39.45 million

Accounts payable

$11.04M
NKGN annual accounts payable is $11.04 million

Debt

Total debt

$19.92M
NKGN annual total debt is $19.92 million

Total debt 1-year change

+65.54%
NKGN annual total debt is up +65.54% year-on-year

Long term debt

$9.93M
NKGN annual long term debt is $9.93 million

Short term debt

$9.99M
NKGN annual short term debt is $9.99 million

Equity & Capital

Shareholders equity

-$58.69M
NKGN annual stockholders equity is -$58.69 million

Book value

-$58.69M
NKGN annual book value is -$58.69 million

Retained earnings

-$162.13M
NKGN annual retained earnings is -$162.13 million

Working capital

-$37.52M
NKGN annual working capital is -$37.52 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$21.95M
NKGN annual cash flow from operations is -$21.95 million

Cash from operations 1-year change

+2.7%
NKGN annual cash flow from operations is up +2.7% year-on-year

Cash from investing

-$48.00K
NKGN annual cash flow from investing activities is -$48.00 thousand

Cash from investing 1-year change

+70.55%
NKGN annual cash flow from investing activities is up +70.55% year-on-year

Cash from financing

$22.16M
NKGN annual cash flow from financing activities is $22.16 million

Cash from financing 1-year change

-1.47%
NKGN annual cash flow from financing activities is down -1.47% year-on-year

CAPEX

CAPEX

-
NKGN annual capital expenditures value is unknown

CAPEX 1-year change

-
NKGN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$22.00M
NKGN annual free cash flow is -$22.00 million

Free cash flow 1-year change

+3.19%
NKGN annual free cash flow is up +3.19% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
NKGN annual gross profit margin value is unknown

Operating margin

-
NKGN annual operating profit margin value is unknown

Net margin

-
NKGN annual net profit margin value is unknown

ROA & ROE

ROA

-503.33%
NKGN annual return on assets is -503.33%

ROE

141.34%
NKGN annual return on equity is 141.34%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
NKGN price to earnings ratio value is unknown

PE ratio Sector rank

-
NKGN price to earnings ratio is unknown

PB Ratio

PB ratio

-0.12
NKGN price to book ratio is -0.12

PB ratio Sector rank

12.83%
NKGN price to book ratio is higher than 12.83% of companies in Healthcare sector

PS Ratio

PS ratio

-
NKGN price to sales ratio value is unknown

PS ratio Sector rank

-
NKGN price to sales ratio is unknown

Enterprise value

Enterprise value

$36.17M
NKGN enterprise value is $36.17 million

Enterprise value Sector rank

37.99%
NKGN enterprise value is higher than 37.99% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.81
NKGN EV/EBITDA is -0.81

EV/EBITDA Sector rank

46.31%
NKGN EV/EBITDA is higher than 46.31% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

0.05
NKGN annual current ratio is 0.05

Quick ratio

-
NKGN annual quick ratio value is unknown

Leverage

Debt to equity

-0.34
NKGN annual debt to equity ratio is -0.34

Interest coverage ratio

-110.34
NKGN annual interest coverage ratio is -110.34

Risk & Stability

Piotroski F-Score

-
NKGN piotroski f-score value is unknown

Altman Z-Score

-
NKGN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

No data about analysts updates

Institutional Ownership

Similar stocks

RSLS logo
ReShape Lifesciences (RSLS)
NLSP logo
NLS Pharmaceutics AG (NLSP)
NAOV logo
NanoVibronix (NAOV)
MSPR logo
MSP Recovery (MSPR)
LMDX logo
LumiraDx Limited (LMDX)
NSTG logo
NanoString Technologies (NSTG)
ALZN logo
Alzamend Neuro (ALZN)
MOVE logo
Movano (MOVE)
GMDA logo
Gamida Cell (GMDA)
  • What is the ticker symbol for NKGen Biotech?
  • Does NKGen Biotech pay dividends?
  • What sector is NKGen Biotech in?
  • What industry is NKGen Biotech in?
  • What country is NKGen Biotech based in?
  • When did NKGen Biotech go public?
  • Is NKGen Biotech in the S&P 500?
  • Is NKGen Biotech in the NASDAQ 100?
  • Is NKGen Biotech in the Dow Jones?
  • When was NKGen Biotech's last earnings report?
  • When does NKGen Biotech report earnings?

What is the ticker symbol for NKGen Biotech?

The ticker symbol for NKGen Biotech is NASDAQ:NKGN

Does NKGen Biotech pay dividends?

No, NKGen Biotech does not pay dividends

What sector is NKGen Biotech in?

NKGen Biotech is in the Healthcare sector

What industry is NKGen Biotech in?

NKGen Biotech is in the Biotechnology industry

What country is NKGen Biotech based in?

NKGen Biotech is headquartered in United States

When did NKGen Biotech go public?

NKGen Biotech's initial public offering (IPO) was on October 2, 2023

Is NKGen Biotech in the S&P 500?

No, NKGen Biotech is not included in the S&P 500 index

Is NKGen Biotech in the NASDAQ 100?

No, NKGen Biotech is not included in the NASDAQ 100 index

Is NKGen Biotech in the Dow Jones?

No, NKGen Biotech is not included in the Dow Jones index

When was NKGen Biotech's last earnings report?

NKGen Biotech's most recent earnings report was on May 20, 2024

When does NKGen Biotech report earnings?

The next expected earnings date for NKGen Biotech is May 20, 2025
On this page